Are these penny stocks worth buying at their current level? Take a look and find out 3 Penny Stocks to Add to Your September 2021… Read More »Do These Penny Stocks Present A Buying Opportunity At Current Prices?
In the face of the delta variant taking hold in the U.S., pandemic-driven demand for packaged foods could be sticking around for longer than had… Read More »Continued Demand For Packaged Food Amid Delta Could Make This Stock A Sweet Deal – Literally.
The clinical-stage biopharmaceutical company discussed in today’s article, which is focused on developing innovative cancer therapies.
COVID case numbers are surging again thanks the Delta variant, and concerns that this will result in more lockdowns and travel restrictions may be part… Read More »The “Delta Scare” Could Be A Great Opportunity To Get In On “The Explosive Small-Cap Energy” Story
With the fast-spreading Delta variant of the coronavirus taking hold in the U.S. and many countries around the world, we may just be entering the… Read More »As We Enter The Second Inning Of The Pandemic, Could This “Dark Horse” COVID Vaccine Stock Win The Long Game?
“With the more contagious delta variant now dominant in the U.S. despite the widespread availability of vaccines, the need for effective treatments is once again… Read More »An Effective Oral Therapy For COVID-19 Could Make This Under-The-Radar Biopharma Company A Big Winner
“Cancer treatments have remained a hotbed for biotech companies.”
The company’s drug for wet AMD had proven to help with the disorder, and thus it seems highly likely it will be approved.
“It was a difficult first half for biotech stocks, once again underscoring how conditions may seem so ideal but investment returns can still be hard… Read More »Why The Coming Months Could Be A “Biotech Bonanza”
“Wall Street analysts following these biotechs have high expectations for the drugs they’re developing and in one case already marketing.